New Books in Drugs, Addiction and Recovery

In Border Contraband: A History of Smuggling Across the Rio Grande (University of Texas Press, 2015) Professor George T. Diaz examines a subject that has received scant attention by historians, but one that is at the heart of contemporary debates over U.S.-Mexico immigration and border enforcement. Focusing on trans-border communities, like Laredo/Nuevo Laredo, Diaz details the interplay between state efforts to regulate cross-border trade and the border people that subverted state and federal laws through acts of petty smuggling and trafficking. Using folk songs (corridos), memoirs, court documents, and newspapers, Diaz uncovers the social history of a transnational contrabandista community that responded to the hardening of the U.S.-Mexico border and the enforcement of trade regulations through the formation of a moral economy. Holding nuanced views of newly erected legal and physical barriers to the mobility of people and consumer goods across the border, contrabandistas established a cultural world of smuggling that regulated trade on its own terms and frustrated state efforts to define and police notions of legality/illegality. Foreshadowing our contemporary moment in which the Rio Grande Valley is associated with criminality, violence, and drug trafficking, Diaz argues, (1) that it was the creation and enforcement of national borders by the U.S. and Mexican states that led to smuggling by establishing a market for contraband goods; and (2) that border people were proactive agents in negotiating and obstructing state efforts to regulate and criminalize activities that were common practice and essential to life along the U.S.-Mexico border. David-James Gonzales (DJ) is a Doctoral Candidate in History at the University of Southern California. He is a historian of the U.S.-Mexico Borderlands, Civil Rights, and Latino Identity & Politics. DJ’s dissertation examines the influence of Mexican American civic engagement and political activism on the metropolitan development of Orange County, CA from 1930 to 1965.   Learn more about your ad choices. Visit megaphone.fm/adchoicesSupport our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

In the early 2000s, the press–at least in Boston, where I was living at the time–was full of shrill stories about drug-crazed addicts breaking into area pharmacies in search of something called “Oxycontin.” I had no idea what Oxycontin was, but I was pretty sure there must be something remarkable about it if ordinary drug fiends were risking jail time and worse by robbing mom-and-pop drug stores to get it. As Sam Quinones explains in his remarkable book Dreamland: The True Tale of American’s Opiate Epidemic (Bloomsbury Press, 2015), the Oxycontin crime wave was an early moment in the emergence of a full-blown Opiate epidemic in the United States. For many young doctors working in “pain management in the 90s and naughts, Oxycontin was remarkable indeed. It gave them just what their predecessors in the eternal fight against pain lacked: a supposedly non-addictive opium-based medication that they could prescribe far and wide without fear of hooking their patients on it. And with all the best intentions, prescribe it far and wide these doctors did. But it wasn’t non-addictive at all; masses of patients become dependent. And not only them. Drug-users learned that “Oxy” afforded a wonderful high, and it became highly coveted “on the street.” The rub was that this new “wonder drug” was either hard to get–unless you had access to a “Pill Mill”–and/or very expensive. So Oxycontin addicts got desperate. Some, like the ones the press was screaming about in Boston, stole the drug from the local CVS and the like. Most, however, turned to an old drug that was easier to get and cheaper: Black Tar Heroin from Mexico. In the wake of Oxycontin, Black Tar spread from the Southwest across much of the U.S., even to places like Western Massachusetts, where I live now and the heroin epidemic is in full, tragic swing. Learn more about your ad choices. Visit megaphone.fm/adchoicesSupport our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

Though the conventional history of the U.S.-led “War on Drugs” locates the origins of this conflict in a reaction to the domestic culture of excess of the 1960s, a new book argues that international drug control efforts are actually decades older, and much more imbricated with the history of U.S. access to international markets, than we have previously thought. Suzanna Reiss’s We Sell Drugs: The Alchemy of US Empire (University of California Press, 2014) uncovers this history by tracing the transnational geography and political economy of coca commodities–stretching from Peru and Bolivia into the United States, and back again. The book examines how economic controls put in place during WWII transformed the power of the U.S. pharmaceutical industry in Latin America and beyond, and gave rise to new definitions of legality and illegality–definitions that were largely premised on who grew, manufactured, distributed, and consumed drugs, and not on the qualities of the drugs themselves. Drug control, she shows, is a powerful tool for ordering international trade, national economies, and society’s habits and daily lives. Learn more about your ad choices. Visit megaphone.fm/adchoicesSupport our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

Kristin Peterson‘s new ethnography looks carefully at the Nigerian pharmaceutical market, paying special attention to the ways that the drug trade links West Africa within a larger global economy. Speculative Markets: Drug Circuits and Derivative Life in Nigeria (Duke University Press, 2015) takes reads into a story that is part medical anthropology, part careful analysis of global economy, and shows that understanding one is vital to understanding the other in the modern West African pharmaceutical landscape. Peterson pays special attention to the Idumota market, an area that was strictly residential in the 1970s and has since become one of the largest West African points of drug distribution for pharmaceuticals and other materials from all over the world. Peterson looks at the consequences of major local and global historical factors in that transformation, including civil war in the late 1960s and migration that followed, a 1970s oil boom and bust, and changes in the global pharmaceutical market in the 1980s. By the early 1980s, Nigeria was deep into an economic crisis that had profound implications for the production, circulation, and marketing of pharmaceuticals. The pharmaceutical industry remade itself by becoming tied to the speculative marketplace, with wide-ranging implications that included the rise of new professional relationships & market formations in Nigeria, new relationships with firms in China and India, new forms of speculation, and new questions about the ontology of markets. Peterson demonstrates that these transformations continue to have important consequences for the bodies of individual Nigerians, including major problems with drug resistance and a mismatch between existing drug therapies and existing diseases. The book avoids the usual discourse of corporate greed, instead focusing on the “structural logics of pharmaceutical capital through which corporate practices can be understood.” It is a timely and fascinating study. Learn more about your ad choices. Visit megaphone.fm/adchoicesSupport our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

Drugs exist that are meant to help people feel better. The doctors who prescribe them might believe that they work, while their patients do not. In explaining the drugs to their patients, should those doctors use the medical terminology they themselves use – which might not be immediately understandable to their patients – or should they translate the description into terms more comfortable and familiar to the patient? And what are the practical and ethical consequences of each decision? Stefan Ecks‘ new book carefully considers these problems in the context of health-related practices in modern Calcutta. Eating Drugs: Psychopharmaceutical Pluralism in India (NYU Press, 2013) looks successively at the different and overlapping medical and healing contexts that together make up a significant part of the medical marketplace in Calcutta. Ch. 1 treats popular notions that include the importance of the belly as the “somatic center of good health,” the power of the mind to regulate good health, and the connection between modernity and pollution as causes of illness. Ch. 2 looks at Ayurvedic practices in Calcutta. It reflects on some of the most important ways that Ayurveda is changing in India – especially at the levels of practitioner training, language, and the patient-physician relationship – despite the fact that the centrality of food and digestion has remained constant. Ch. 3 looks closely at homeopathy, the second most popular type of medicine in Bengal, and focuses on the principles, histories, and pluralities of homeopathic practices in Calcutta. Ch. 4 looks at the ways that Calcutta psychiatrists position themselves with respect to popular beliefs about psychopharmaceuticals, general physicians, practitioners of non-biomedical treatments, and the pharmaceutical industry. This chapter pays special attention to how Bengali doctors use metaphors to help patients understand and respond to psychiatric diagnoses, with comparisons to nature, the Ganges river, fairytales, everyday over-the-counter drugs, diabetes, and food. The conclusion explores a key argument of the book, proposing that “patients’ suspicions of psychopharmaceuticals are based on suspicions of biomedicine’s ‘magic bullet’ model of drug effects,” looking at the implications of this conclusion, and considering the possible broader impacts of this study beyond Calcutta. It’s a fascinating study of potential interest to historians and anthropologists of medicine and healing, as well as readers interested in learning more about the medical marketplace of modern India and anyone interested in modern psychopharmaceuticals. Learn more about your ad choices. Visit megaphone.fm/adchoicesSupport our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

Paul A. Christensen‘s new book is a thoughtful ethnography of drinking, drunkenness, and male sociability in modern urban Japan. Focusing on two major alcohol sobriety support groups in Japan, Alcoholics Anonymous and Danshukai, Japan, Alcoholism, and Masculinity: Suffering Sobriety in Tokyo (Lexington Books, 2014) explores the ways that admitting to and living with alcoholism in Japan challenges prevailing norms of masculinity and sociability, and looks carefully at its profound consequences for the individual sufferer. After a brief history of alcohol and drunkenness in Japan, Christensen considers the ubiquitous coding of alcohol as fun and leisurely in mass media, and directs our attention to the difficulties that this framing creates for male alcoholics. The book then moves to a discussion of historical shifts in notions of addiction in Japan, as well as contemporary debates over treatment methodologies and the ways that methodologies transplanted into Japan from the US map – or not – onto local cultural and religious realities. Christensen follows this with detailed accounts of the major support groups available to sufferers in Tokyo, the languages and bodies of alcoholic experience, and much else. Throughout the study, Christensen offers an extraordinarily sensitive treatment of the struggle of individual men to build a new selfhood while their sense of masculinity, and of a place in society, have been dismantled. Learn more about your ad choices. Visit megaphone.fm/adchoicesSupport our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

Todd Meyers‘ The Clinic and Elsewhere: Addiction, Adolescents, and the Afterlife of Therapy (University of Washington Press, 2013) is many things, all of them compelling and fully realized. Most directly, the book is an ethnography of drug dependence and treatment among adolescents in Baltimore between 2005-2008. Meyers traces twelve people through their treatment in the clinic and beyond, into what he calls “the afterlife of therapy.” The group of adolescents was diverse–their economic and family circumstances, their demographics, and arc of their narratives from addiction to treatment varied widely. Yet they shared at least one important experience: “each had either been enrolled in a clinical trial or were currently being treated with a relatively new drug for opiate withdrawal and replacement therapy: buprenorphine” (4). In this way, the book is also the story of a pharmaceutical making its way and its mark in the worlds of therapeutics, law, public opinion and, especially, in the lives of its users. Meyers shows how the lives and experiences of these adolescents (as well as others in their lives) were often shaped and constrained by their roles as subjects in pharmaceutical trials evaluating the effectiveness of buprenorphine. Moreover, Meyers looks beyond the questions and answers asked and answered under the constraints of randomized controlled trials. Rather, as he puts it, “my ethnographic gaze is fixed upon the intersection of clinical medicine and social life, at the place where medical and pharmacological subjects are constituted under the sign of therapeutics” (17). As a result, The Clinic as Elsewhere locates palpable places where medicine and the social intersect in the material world and lived experience; as readers, we see the relationship between the medical and the social as much as understand it as a conceptual given. Ultimately, Meyers shows how therapeutics is not only a form of intervention, but a “sign”: under which people are constituted as subjects, and with which people “assign value, meaning, and worth assign value to pharmaceutical intervention” (116). Learn more about your ad choices. Visit megaphone.fm/adchoicesSupport our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

DMT and the Soul of Prophecy:A New Science of Spiritual Revelation in the Hebrew Bible (Park Street Press, 2014) asks a number of provocative questions about drugs, consciousness, prophecy, and the Hebrew Bible–with attention to how a particular chemical can help us understand mystical experience. DMT (dimethyltryptamine) is a molecule endogenous to several mammals including humans, as well as the active psychedelic ingredient in a number of plant species around the world–most notably in an Amazonian brew called ayahuasca. Rick Strassman‘s first book, DMT: The Spirit Molecule, showcases his research in the 1990s at the University of New Mexico, during which he injected several volunteers with DMT as part of a government-sanctioned research project. During the trials, volunteers experienced a number of similar phenomena, such as communication with other-than-human beings, out-of-body experiences, and geometrically complex closed-eye visuals. DMT and the Soul of Prophecy complements Strassman’s first book, but it also stands on its own and gives enough context of his DMT research to make sense of his arguments about prophecy in the Hebrew Bible. The new monograph aims to further interpret the data from Strassman’s experiments in the 90s, by arguing that the notion of prophecy in the Hebrew Bible offers a compelling model for what happens in the DMT state. One might ask, then, if the Hebrew prophets were affected by DMT. Although it’s not possible to know for sure, and Strassman doesn’t claim that they were, he nonetheless draws significant parallels between DMT experiences and prophetic states in the Hebrew Bible. At the cross-section of biology, psychology, and religious studies, Strassman’s monograph is sure to spark provocative conversations about the relationship between religion, drugs, and the politics of research. Learn more about your ad choices. Visit megaphone.fm/adchoicesSupport our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

Commercial interests are often understood as impinging upon the ethical norms of medicine. In his new book, Medical Monopoly: Intellectual Property Rights and the Origins of the Modern Pharmaceutical Industry (University of Chicago Press, 2013), Joe Gabriel shows how the modernization of American medicine was bound up in the ownership, manufacture, and marketing of drugs. Gabriel unearths the early history of intellectual property concerns as they entered the domain of medical practice itself. Through his careful marshaling of evidence, he takes readers back to a time when the norms and legal structures of commercial capitalism in the U.S. were just as much at issue as those of the professionalization of medicine. This fascinating book serves as a pointed reminder that the sources of therapeutic rationale are just as much tied to the production and regulation of therapies as the collective decision-making on ethical practice. Along with my previous interview with Jeremy Greene, this discussion will hopefully make accessible a broad perspective on the development of medicine in the 20th century by focusing on its ties to industry. Medical Monopoly charts the history of property rights over medicines at the dawn of the 19th century through World War I. The important broader transition here is that while before the Civil War–at least in medicine–patents were seen as tantamount to granting problematic monopoly, by the end of the 19th century they were understood as the best available regulatory mechanism for preventing more problematic imitation. Whereas patent medicines had previously been linked to quackery, the emergence and rapid expansion of the “ethical” pharmaceutical industry after the Civil War was due to its adherents advocating for more effective regulation of commerce within medicine. Rather than reverting to secrecy, firms began to circulate and publish information on new remedies and the results of studies to physicians. As the explosion of new medicines remained at pace with the boom of consumer goods in the late 19th century, patenting and corporate investment in monopolistic practices became understood as a mechanism to advance the public good. The expansion of laboratory science and norms of chemical manufacturing in the 20th century only bolstered this union further.Medical Monopoly is a fascinating and important read that people interested in medical policy should pay attention to. Learn more about your ad choices. Visit megaphone.fm/adchoicesSupport our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

Is pain real? Is pain relief a right? Who decides? In Pain: A Political History (Johns Hopkins University Press, 2014),Keith Wailoo investigates how people have interpreted and judged the suffering of others in the US from the mid-1940s to the present. While doctors and patients figure in his story, the primary protagonists are politicians, judges, and ideologues, who variously understood the ambiguities of pain as political problems to be settled in legislatures and in courts of law and public opinion alike. For instance, in the 1940s and 1950s, the “pain complaint” of ailing World War II veterans became the locus of debates about manhood, federal disability benefits, and pharmaceutical interventions. Although physicians faced complex problems about adjudicating the pain of their patients, Wailoo shows that pain was also a deeply cultural problem, especially as new, competing theories of pain emerged to explain not only the experience of suffering, but the character, motives, and rights and responsibilities of the sufferer. In the Reagan administration-era, debates about pain were an index of America’s welfare problem, and in late 20thcentury, controversies over fetal pain and the “ultimate relief” of physician-assisted suicide reflected the polarized landscape of “liberal” and “conservative” positions. The last chapter, “OxyContin Unleashed,” compellingly shows how a de-regulated and pro-business pain policy led to the pain drug boom in a competitive and unstable medical marketplace. Ultimately, Wailoo claims that “we have a cultural problem understanding people’s pain.” Pain shows us how that has taken place throughout our recent history, and challenges us to acknowledge and attend to the way that we politicize the pain of others without regard for their suffering. Learn more about your ad choices. Visit megaphone.fm/adchoicesSupport our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery